AKIN GUMP STRAUSS HAUER & FELD

Lobbying for GENENTECH INC · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $50,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Health Issues

Issues related to public health preparedness; Issues related to access to medicines for minority communities; Issues related to healthcare education and screening.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.